Organic electroluminescent materials and devices
US-2024292736-A1 · Aug 29, 2024 · US
US9502672B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9502672-B2 |
| Application number | US-201313798917-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 13, 2013 |
| Priority date | Jun 21, 2012 |
| Publication date | Nov 22, 2016 |
| Grant date | Nov 22, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A phenazasiline comprising compound, and devices and formulations including the same are described. The compound includes a ligand L 1 including: wherein E 1 is N, E 2 is Si, and R 4 and R 5 represent mono, di, tri, tetra substitutions or no substitution; wherein R 1 , R 2 , R 3 , R 4 , and R 5 are each independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and any two adjacent R 1 , R 2 , R 3 , R 4 , and R 5 , are optionally joined to form a ring, which may be further substituted. In Formula I, L 1 is coordinated to metal M, which has an atomic weight higher than 40, provided that the metal M does not form bond with E 1 and E 2 . L 1 may be linked with other ligands.
Opening claim text (preview).
We claim: 1. A compound having a structure of Formula II: wherein metal M has an atomic weight higher than 40; wherein R 5 represents mono, di, tri, tetra substitutions or no substitution; wherein R 4 represents mono, di, or tri substitutions; wherein each L 2 is a ligand coordinated to the metal M; wherein each L 2 can be the same or different; wherein R 1 , R 2 , R 3 , R 4 , and R 5 are each independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein one R 4 is coordinated to the metal M; wherein any two adjacent R 2 , R 3 , R 4 , and R 5 are optionally joined to form a ring, which may be further substituted; wherein the metal M does not form a direct bond with the N or the Si of Formula II; wherein any of R 1 , R 2 , R 3 , and R 4 are optionally linked to L 2 to comprise a tridentate, tetradentate, pentadentate or hexadentate ligand; wherein m is a value from 1 to the maximum number of ligands that may be attached to the metal M; and wherein m+n is the maximum number of ligands that may be attached to the metal M. 2. The compound of claim 1 , wherein the metal M is a metal selected from the group consisting of Ir, Pt, Re, Os, Ru, Rh, Pd, Cu, Ag, and Au. 3. The compound of claim 1 , wherein the metal M is Ir. 4. The compound of claim 1 , wherein the metal M is Pt. 5. The compound of claim 1 , wherein at least one of R 1 , R 2 , and R 3 is aryl or substituted aryl. 6. The compound of claim 5 , wherein at least one of R 1 , R 2 , and R 3 is phenyl or substituted phenyl. 7. The compound of claim 1 , wherein the compound is homoleptic. 8. The compound of claim 1 , wherein the compound is heteroleptic. 9. The compound of claim 8 , wherein L 2 or part of L 2 if L 2 is more than bidentate is selected from the group consisting of: wherein R a , R b , R c , and R d may represent mono, di, tri, or tetra substitution, or no substitution; wherein R a , R b , R c , and R d are independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfanyl, sulfonyl, phosphino, and combinations thereof; and wherein two adjacent substituents of R a , R b , R c , and R d are optionally joined to form a fused ring or form a multidentate ligand. 10. The compound of claim 1 , wherein at least one of R 1 , R 2 , and R 3 are linked to L 2 to comprise a tridentate, tetradentate, pentadentate or hexadentate ligand. 11. The compound of claim 1 , wherein the compound is selected from the group consisting of: wherein X 1 , X 2 is selected from the group consisting of C, N, O, P, S, and B; wherein A is a 5-membered or 6-membered carbocyclic or heterocyclic ring; wherein R 6 represents mono, di, tri, tetra substitutions or no substitution; wherein R 6 is selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein any two adjacent R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 are optionally joined to form a ring, which may be further substituted. 12. The compound of claim 11 , wherein A is selected from the group consisting of: wherein Y is selected from the group consisting of BR, NR, PR, O, S, Se, C═O, S═O, SO 2 , CRR′, SiRR′, and GeRR; wherein R, R′ are independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfanyl, sulfonyl, phosphino, and combinations thereof; and wherein R, R′ are optionally joined to form a ring with any adjacent substituent. 13. The compound of claim 1 , wherein the compound is selected from the group consisting of: 14. The compound of claim 13 , wherein m is 3, and n is 0. 15. The compound of claim 13 , wherein m is 1, and n is 2. 16. The compound of claim 13 , wherein L 2 is selected from the group consisting of: 17. The compound of claim 1 , wherein the compound is selected from the group consisting of: 18. The compound of claim 1 , wherein R 1 comprises a 5-membered or 6-membered carbocyclic or heterocyclic aromatic ring; and wherein R 1 is coordinated to the metal M. 19. The compound of claim 1 , wherein R 2 comprises a 5-membered or 6-membered carbocyclic or heterocyclic aromatic ring; and wherein R 2 is coordinated to the metal M. 20. The compound of claim 18 , wherein R 1 comprises at least one of the chemical groups selected from the group consisting of:
Non-condensed systems · CPC title
containing one nitrogen atom as the heteroatom · CPC title
containing organic luminescent materials · CPC title
containing two nitrogen atoms as heteroatoms · CPC title
containing sulfur as the only heteroatom · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.